In cHL, the Hodgkin Reed-Sternberg (HRS) cells produce vascular endothelial growth factor (VEGF) which induces regulatory T-cell proliferation and increases the expression of inhibitory receptors, including PD-1 (31). The gene discussed is VEGFA; the disease is classic Hodgkin lymphoma.